ResearcherMedical University of SilesiaActive in the last 2 years
Elżbieta Świętochowska
Matched on ORCID iD 0000-0001-5787-7880; OpenAlex author ID A5044458634. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 6
2016: 1 paper · 2017: none · 2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper · 2024: 1 paper
Papers 4
- Evaluations of the combined use of blood- and tissue-based protein biomarkers for pancreatic cancer. Co-author DOI 10.3233/ch-231987↗
- Blood-based protein biomarkers and red blood cell aggregation in pancreatic cancer. Co-author DOI 10.3233/ch-231814↗
- Serum omentin-1 and chemerin concentrations in pancreatic cancer and chronic pancreatitis. Last author DOI 10.24425/fmc.2018.124660↗
- The role of the tissue plasminogen activator as a prognostic and differentiation factor in patients with pancreatic cancer and chronic pancreatitis. Co-author PMID 27010898↗
Closest collaborators
The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Maciej Wiewióra · 3 shared papers, 2018–2024 · strength 0.58
- Paper Evaluations of the combined use of blood- and tissue-based protein biomarkers for pancreatic cancer. DOI 10.3233/ch-231987↗
- Paper Blood-based protein biomarkers and red blood cell aggregation in pancreatic cancer. DOI 10.3233/ch-231814↗
- Paper Serum omentin-1 and chemerin concentrations in pancreatic cancer and chronic pancreatitis. DOI 10.24425/fmc.2018.124660↗
- Jerzy Piecuch · 3 shared papers, 2018–2024 · strength 0.58
- Paper Evaluations of the combined use of blood- and tissue-based protein biomarkers for pancreatic cancer. DOI 10.3233/ch-231987↗
- Paper Blood-based protein biomarkers and red blood cell aggregation in pancreatic cancer. DOI 10.3233/ch-231814↗
- Paper Serum omentin-1 and chemerin concentrations in pancreatic cancer and chronic pancreatitis. DOI 10.24425/fmc.2018.124660↗
- Paweł Kiczmer · 1 shared paper, 2018 · strength 0.09
- D Baluka · 1 shared paper, 2016 · strength 0.06
- Andrzej Lekstan · 1 shared paper, 2016 · strength 0.06
- Paweł Lampe · 1 shared paper, 2016 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.